Cereset Research Exploratory Study

Description

The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

Conditions

Neurological Diseases or Conditions, Cardiovascular Conditions After Birth, Psychophysiologic Disorders

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

Cereset Research Exploratory Study

Cereset Research Exploratory Study

Condition
Neurological Diseases or Conditions
Intervention / Treatment

-

Contacts and Locations

Winston-Salem

Department of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States, 27104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects must have the ability to comply with basic instructions and be able to sit still comfortably with the sensor leads attached
  • * Subjects experiencing symptoms of stress, anxiety, or insomnia, who meet threshold scores on one or more self-reported inventories for the same. This includes the Insomnia Severity Index (ISI, ≥ 8), the Perceived Stress Index (PSS, ≥ 14), or the Generalized Anxiety Disorder 7-item (GAD-7, ≥ 5) scale.
  • * Unable, unwilling, or incompetent to provide informed consent/assent.
  • * Physically unable to come to the study visits, or to sit comfortably in a chair for up to 1.5 hours.
  • * Severe hearing impairment (because the subject will be using ear buds during CR).
  • * Anticipated and ongoing use of alcohol or recreational drugs.
  • * Weight is over the chair limit (285 pounds).
  • * Currently in another active intervention research study.
  • * Prior use of HIRREM, Brainwave Optimization, Cereset, or a wearable configuration of the same (B2, or B2v2).
  • * Prior use of electroconvulsive therapy (ECT).
  • * Prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, neurofeedback, biofeedback, or deep brain stimulation (DBS) within one month before enrollment.
  • * Known seizure disorder.

Ages Eligible for Study

11 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wake Forest University Health Sciences,

Charles Tegeler, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

2026-04